Smart Pills Market, Size, Global Forecast 2024-2032, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis
Buy NowGlobal Smart Pills Market Outlook
Global Smart Pills Market is predicted to reach US$ 13.35 Billion by 2032, according to Renub Research. In the near future, the convergence of pharmaceuticals and digital technology guarantees a groundbreaking shift in healthcare through smart pills. These innovative pills, embedded with sensors or tiny computer systems, provide a dynamic medication delivery and tracking approach. By seamlessly integrating into patients' everyday routines, smart capsules enhance remedy adherence and provide real-time facts to healthcare providers, allowing personalized care and timely interventions. This synergy between medicinal drugs and technology can revolutionize healthcare, improving patient outcomes and reworking how diseases are handled.
Global Smart Pills Market is expected to increase at a CAGR of 12.84% from 2024 to 2032
The surge in chronic diseases is propelling the global smart pills market. The World Health Organization (WHO) predicts that by 2050, non-communicable diseases (NCDs) like cardiovascular illnesses, cancer, diabetes, and respiration problems will contribute to 86% of the projected 90 million annual deaths. The escalating occurrence of such situations internationally fuels the demand for revolutionary healthcare solutions, mainly smart pills. These technological improvements permit advanced tracking and management of chronic illnesses, enhancing patient care and effects in the long run. Positioned as a critical player, the smart pills market has the potential to revolutionize disease management, addressing the evolving healthcare landscape formed by the growing burden of chronic health problems.
Furthermore, the increasing need for sophisticated drug delivery systems drives the global smart pills market. These systems provide benefits, including efficient utilization of active pharmaceutical substances, reduced dosage frequency, limited adverse consequences, precise drug delivery, and more secure transporters. The amalgamation of modern drugs, scientific equipment, and superior technology is anticipated to noticeably elevate the global smart pills market in the foreseeable future. A giant portion of the market is expected to contain patients suffering chronic conditions requiring precise medicinal drug doses at specific sites, forming a significant customer base for superior drug delivery products. Consequently, the Global Smart Pills Market was priced at US$ 4.50 Billion in 2023.
The increased demand for minimally invasive surgical procedures has spurred innovation, including capsule endoscopy, which provides more ease of use and distinct gastrointestinal tract observation and is likely supplanting traditional techniques. Moreover, clinical errors from human involvement in specialty drug distribution prompt a shift towards value-based patient care in the US, propelling smart pill demand. The burgeoning development of smart pill facilities in the United States, exemplified by Accelmed Partners' $40 million investment in MedMinder Systems Inc. in March 2022, underscores the growth of the smart pill market.
Capsule endoscopy could emerge as a prominent application within the global smart pills market
By application, the Global Smart Pills Market is fragmented into Capsule Endoscopy, Patient Monitoring, and Drug Delivery. Capsule endoscopy might stand out as a leading application in the global smart pills market. This is because of its minimally invasive nature and complete visualization skills of the gastrointestinal tract. Capsule endoscopy, which provides ease of management and targeted examination without requiring traditional endoscopic approaches, is increasingly preferred by sufferers and healthcare companies. Its ability to offer accurate diagnostic facts while ensuring patient comfort and convenience positions it as an essential driver in the continued increase of the smart pills market.
Esophagus represents a notable segment within the global smart pills market
Global Smart Pills Market is segmented by target area into Esophagus, Small Intestine, Large Intestine, and Stomach. The esophagus is among the significant segments in the global smart pills market. This is due to its crucial role in digestive health and the diagnosis of various gastrointestinal disorders. Smart pills designed for esophageal tracking provide a non-invasive and convenient technique for assessing situations like gastroesophageal reflux disease (GERD), esophagitis, and Barrett's esophagus. By providing real-time data on esophageal features and potential abnormalities, these smart pills enable early detection, specific analysis, and personalized remedy techniques, driving their need and adoption in the healthcare enterprise.
Diagnostic centers can potentially become a substantial segment within the global smart pills market
By end-users, the Global Smart Pills Market is categorized into Diagnostic Centers, Hospitals, Research Institutes, and Others. Diagnostic centers could emerge as a considerable global smart pills market segment. This is owed to their pivotal role in healthcare diagnostics. Smart pills offer a non-invasive and efficient technique for diagnosing gastrointestinal issues and tracking situations, including colon cancer, Crohn's sickness, and minor bowel issues. Integrating smart pill technology into diagnostic center services enhances diagnostic accuracy, patient comfort, and universal healthcare performance, propelling their adoption and prominence in the smart pills market.
United States leads in the global smart pills Market
Based on country, the global smart pills market is organized into North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, the Netherlands, and Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, and New Zealand), Latin America (Brazil, Mexico, and Argentina), Middle East & Africa (South Africa, Saudi Arabia, and the United Arab Emirates). The United States asserts dominance in the global smart pills market. This is attributed to its advanced healthcare infrastructure, robust technological innovation, and a high prevalence of chronic diseases. With a focus on value-based care and early disease detection, the country leads in adopting smart pill technology for improved diagnostics and monitoring. Extensive research and development initiatives and strategic collaborations between healthcare providers and technology firms further propel the U.S. as a frontrunner in shaping the future of smart healthcare solutions, contributing significantly to its market dominance.
Key Players
The global smart pills market companies are Check-Cap Ltd., General Electric Company, Fujifilm, Koninklijke Philips N.V., Medtronic plc, Olympus Corporation, Novartis AG, and Otsuka Holdings Co., Ltd.
- In September 2022 - HealthBeacon plc expanded its platform to handle intricate medication schedules with its new offering, the HB Smart Pills Management System, addressing critical medication management needs.
Application – Global Smart PillsMarket breakup in 3 viewpoints:
1. Capsule Endoscopy
2. Patient Monitoring
3. Drug Delivery
Target Area – Global Smart Pills Market breakup in 4 viewpoints:
1. Esophagus
2. Small Intestine
3. Large Intestine
4. Stomach
End-Users – Global Smart Pills Market breakup in 4 viewpoints:
1. Diagnostic Centers
2. Hospitals
3. Research Institutes
4. Others
Country – Global Smart Pills Market breakup of 25 Countries Covered in the Report:
1. North America
1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
• Overview
• Recent Development
• Revenue Analysis
Company Analysis:
1. Check-Cap Ltd.
2. General Electric Company
3. Fujifilm
4. Koninklijke Philips N.V.
5. Medtronic plc
6. Olympus Corporation
7. Novartis AG
8. Otsuka Holdings Co., Ltd.
Report Details:
| Report Features | Details |
| Base Year | 2023 |
| Historical Period | 2019 – 2023 |
| Forecast Period | 2024 – 2032 |
| Market | US$ Billion |
| Segment Covered | Application, Target Area, End-User, and Countries |
| Countries Covered | United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, Brazil, Mexico, Argentina, Saudi Arabia, United Arab Emirates, and South Africa |
| Companies Covered | Check-Cap Ltd., General Electric Company, Fujifilm, Koninklijke Philips N.V., Medtronic plc, Olympus Corporation, Novartis AG, and Otsuka Holdings Co., Ltd. |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Smart Pills Market
6. Market Share – Global Smart PillsMarket
6.1 By Application
6.2 By Target Area
6.3 By End Users
6.4 By Country
7. Application – Global Smart Pills Market
7.1 Capsule Endoscopy
7.2 Patient Monitoring
7.3 Drug Delivery
8. Target Area- Global Smart Pills Market
8.1 Esophagus
8.2 Small Intestine
8.3 Large Intestine
8.4 Stomach
9. End Users – Global Smart Pills Market
9.1 Diagnostic Centers
9.2 Hospitals
9.3 Research Institutes
9.4 Others
10. Country – Global Smart Pills Market
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand
10.4 Latin America
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina
10.5 Middle East & Africa
10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa
11. Porter’s Five Analysis – Global Smart Pills Market
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis – Global Smart Pills Market
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat
13. Company Analysis
13.1 Check-Cap Ltd.
13.1.1 Company Overview
13.1.2 Product Portfolio
13.1.3 Financial Performance
13.1.4 Recent Developments/Updates
13.2 General Electric Company
13.2.1 Company Overview
13.2.2 Product Portfolio
13.2.3 Financial Performance
13.2.4 Recent Developments/Updates
13.3 Fujifilm
13.3.1 Company Overview
13.3.2 Product Portfolio
13.3.3 Financial Performance
13.3.4 Recent Developments/Updates
13.4 Koninklijke Philips N.V.
13.4.1 Company Overview
13.4.2 Product Portfolio
13.4.3 Financial Performance
13.4.4 Recent Developments/Updates
13.5 Medtronic plc
13.5.1 Company Overview
13.5.2 Product Portfolio
13.5.3 Financial Performance
13.5.4 Recent Developments/Updates
13.6 Olympus Corporation
13.6.1 Company Overview
13.6.2 Product Portfolio
13.6.3 Financial Performance
13.6.4 Recent Developments/Updates
13.7 Novartis AG
13.7.1 Company Overview
13.7.2 Product Portfolio
13.7.3 Financial Performance
13.7.4 Recent Developments/Updates
13.8 Otsuka Holdings Co., Ltd.
13.8.1 Company Overview
13.8.2 Product Portfolio
13.8.3 Financial Performance
13.8.4 Recent Developments/Updates
List of Figures:
Figure-01: Global – Smart Pills Market (Billion US$), 2019 – 2023
Figure-02: Global – Forecast for Smart Pills Market (Billion US$), 2024 – 2032
Figure-03: Application – Capsule Endoscopy Market (Million US$), 2019 – 2023
Figure-04: Application – Forecast for Capsule Endoscopy Market (Million US$), 2024 – 2032
Figure-05: Application – Patient Monitoring Market (Million US$), 2019 – 2023
Figure-06: Application – Forecast for Patient Monitoring Market (Million US$), 2024 – 2032
Figure-07: Application – Drug Delivery Market (Million US$), 2019 – 2023
Figure-08: Application – Forecast for Drug Delivery Market (Million US$), 2024 – 2032
Figure-09: Target Area – Esophagus Market (Million US$), 2019 – 2023
Figure-10: Target Area – Forecast for Esophagus Market (Million US$), 2024 – 2032
Figure-11: Target Area – Small Intestine Market (Million US$), 2019 – 2023
Figure-12: Target Area – Forecast for Small Intestine Market (Million US$), 2024 – 2032
Figure-13: Target Area – Large Intestine Market (Million US$), 2019 – 2023
Figure-14: Target Area – Forecast for Large Intestine Market (Million US$), 2024 – 2032
Figure-15: Target Area – Stomach Market (Million US$), 2019 – 2023
Figure-16: Target Area – Forecast for Stomach Market (Million US$), 2024 – 2032
Figure-17: End User – Diagnostic Centers Market (Million US$), 2019 – 2023
Figure-18: End User – Forecast for Diagnostic Centers Market (Million US$), 2024 – 2032
Figure-19: End User – Hospitals Market (Million US$), 2019 – 2023
Figure-20: End User – Forecast for Hospitals Market (Million US$), 2024 – 2032
Figure-21: End User – Research Institutes Market (Million US$), 2019 – 2023
Figure-22: End User – Forecast for Research Institutes Market (Million US$), 2024 – 2032
Figure-23: End User – Others Market (Million US$), 2019 – 2023
Figure-24: End User – Forecast for Others Market (Million US$), 2024 – 2032
Figure-25: United States – Smart Pills Market (Million US$), 2019 – 2023
Figure-26: United States – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-27: Canada – Smart Pills Market (Million US$), 2019 – 2023
Figure-28: Canada – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-29: France – Smart Pills Market (Million US$), 2019 – 2023
Figure-30: France – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-31: Germany – Smart Pills Market (Million US$), 2019 – 2023
Figure-32: Germany – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-33: Italy – Smart Pills Market (Million US$), 2019 – 2023
Figure-34: Italy – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-35: Spain – Smart Pills Market (Million US$), 2019 – 2023
Figure-36: Spain – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-37: United Kingdom – Smart Pills Market (Million US$), 2019 – 2023
Figure-38: United Kingdom – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-39: Belgium – Smart Pills Market (Million US$), 2019 – 2023
Figure-40: Belgium – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-41: Netherlands – Smart Pills Market (Million US$), 2019 – 2023
Figure-42: Netherlands – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-43: Turkey – Smart Pills Market (Million US$), 2019 – 2023
Figure-44: Turkey – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-45: China – Smart Pills Market (Million US$), 2019 – 2023
Figure-46: China – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-47: Japan – Smart Pills Market (Million US$), 2019 – 2023
Figure-48: Japan – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-49: India – Smart Pills Market (Million US$), 2019 – 2023
Figure-50: India – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-51: South Korea – Smart Pills Market (Million US$), 2019 – 2023
Figure-52: South Korea – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-53: Thailand – Smart Pills Market (Million US$), 2019 – 2023
Figure-54: Thailand – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-55: Malaysia – Smart Pills Market (Million US$), 2019 – 2023
Figure-56: Malaysia – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-57: Indonesia – Smart Pills Market (Million US$), 2019 – 2023
Figure-58: Indonesia – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-59: Australia – Smart Pills Market (Million US$), 2019 – 2023
Figure-60: Australia – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-61: New Zealand – Smart Pills Market (Million US$), 2019 – 2023
Figure-62: New Zealand – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-63: Brazil – Smart Pills Market (Million US$), 2019 – 2023
Figure-64: Brazil – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-65: Mexico – Smart Pills Market (Million US$), 2019 – 2023
Figure-66: Mexico – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-67: Argentina – Smart Pills Market (Million US$), 2019 – 2023
Figure-68: Argentina – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-69: Saudi Arabia – Smart Pills Market (Million US$), 2019 – 2023
Figure-70: Saudi Arabia – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-71: UAE – Smart Pills Market (Million US$), 2019 – 2023
Figure-72: UAE – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-73: South Africa – Smart Pills Market (Million US$), 2019 – 2023
Figure-74: South Africa – Forecast for Smart Pills Market (Million US$), 2024 – 2032
Figure-75: Check-Cap Ltd. – Global Revenue Market (Million US$), 2019 – 2023
Figure-76: Check-Cap Ltd. – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-77: General Electric Company – Global Revenue Market (Million US$), 2019 – 2023
Figure-78: General Electric Company – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-79: Fujifilm – Global Revenue Market (Million US$), 2019 – 2023
Figure-80: Fujifilm – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-81: Koninklijke Philips N.V. – Global Revenue Market (Million US$), 2019 – 2023
Figure-82: Koninklijke Philips N.V. – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-83: Medtronic plc – Global Revenue Market (Million US$), 2019 – 2023
Figure-84: Medtronic plc – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-85: Olympus Corporation – Global Revenue Market (Million US$), 2019 – 2023
Figure-86: Olympus Corporation – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-87: Novartis AG – Global Revenue Market (Million US$), 2019 – 2023
Figure-88: Novartis AG – Forecast for Global Revenue Market (Million US$), 2024 – 2032
Figure-89: Otsuka Holdings Co., Ltd. – Global Revenue Market (Million US$), 2019 – 2023
Figure-90: Otsuka Holdings Co., Ltd. – Forecast for Global Revenue Market (Million US$), 2024 – 2032
List of Tables:
Table-01: Global – Smart Pills Market Share by Application (Percent), 2019 – 2023
Table-02: Global – Forecast for Smart Pills Market Share by Application (Percent), 2024 – 2032
Table-03: Global – Smart Pills Market Share by Target Area (Percent), 2019 – 2023
Table-04: Global – Forecast for Smart Pills Market Share by Target Area (Percent), 2024 – 2032
Table-05: Global – Smart Pills Market Share by End User (Percent), 2019 – 2023
Table-06: Global – Forecast for Smart Pills Market Share by End User (Percent), 2024 – 2032
Table-07: Global – Smart Pills Market Share by Countries (Percent), 2019 – 2023
Table-08: Global – Forecast for Smart Pills Market Share by Countries (Percent), 2024 – 2032
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com